Adolescent Depression: Video Ads on Instagram

November 6, 2024 updated by: Yale University

Reducing Depression-related Stigma and Increasing Help-seeking Intentions: a Randomized Trial of Video Ads on Instagram

The purposes of this study are to test among adolescent viewers the utility of different types of selfie short video-based messaging to:

  1. Reduce stigma and self-stigma related to depression, and
  2. Increase treatment-seeking intentions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Intervention videos will each be self-recorded videos (of ~90-second duration) featuring the same underage professional (ages 16) acting as simulated participant. The investigators will post three brief videos ('video Ads') to achieve similar exposure among Instagram users, 14-18-year-old. The videos are: (a) depression video; (b) depression video adjusted to race experiences, and (c) control videos. All videos will feature by the same Black adolescent girl.

The investigators intend to assign ~10,000 individuals aged 14-18 in a randomized way, in equal proportions, and stratified by sex and race, to view one of the three videos.

Outcomes will include:

  1. Primary outcome: engagement (a composite of likes, shares, comments, and views)
  2. Secondary outcome: clicks on a designated link at the end of the video ad.

Study Type

Interventional

Enrollment (Actual)

1235

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Connecticut
      • New Haven, Connecticut, United States, 06510
        • Yale Child Study Center
      • New Haven, Connecticut, United States, 06510
        • Yale Child Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • English-speaking
  • Living in the US
  • Ages 14 - 18

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Depression
Adolescent depression
Behavioral: Depression
~90-second selfie video of an adolescent discussing her history of depression, treatment, and recovery
Active Comparator: Depression, adjusted
Adolescent depression, impacted by racism
Behavioral: Depression, adjusted
~90-second selfie video of an adolescent discussing her history of depression, treatment, and recovery - and including explicit reference to the role of anti-Black racism as a contributing factor
Active Comparator: Control
Control condition
Behavioral: Control
~90-second selfie video of an adolescent discussing everyday activities and interests, with no reference to depression or racism.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Engagement composite
Time Frame: Day 1: within 10 minutes of viewing the ad

A sum of views, likes, shares, and comments on Instagram.

The composite is an ordinal number ranging from 0 to n; higher values indicate greater engagement with the Instagram add.
Day 1: within 10 minutes of viewing the ad

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clicks on designated link
Time Frame: Day 1: within 10 minutes of viewing the ad

The number of clicks on a designated link at the end of the video ad.

Clicks are an ordinal number ranging from 0 to n; higher values indicate greater engagement with the Instagram add.
Day 1: within 10 minutes of viewing the ad

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2024

Primary Completion (Actual)

September 1, 2024

Study Completion (Actual)

September 1, 2024

Study Registration Dates

First Submitted

February 15, 2023

First Submitted That Met QC Criteria

February 28, 2023

First Posted (Actual)

March 6, 2023

Study Record Updates

Last Update Posted (Estimated)

November 8, 2024

Last Update Submitted That Met QC Criteria

November 6, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2000028980_e
  • No NIH funding (Other Identifier: 11.09.23)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Depression

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe